Cargando…

A prognostic model for elderly patients with squamous non-small cell lung cancer: a population-based study

BACKGROUND: Squamous cell carcinoma (SCC) is a main pathological type of non-small cell lung cancer. It is common among elderly patients with poor prognosis. We aimed to establish an accurate nomogram to predict survival for elderly patients (≥ 60 years old) with SCC based on the Surveillance, Epide...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Siying, Gao, Chunxia, Du, Qian, Tang, Lina, You, Haisheng, Dong, Yalin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670679/ https://www.ncbi.nlm.nih.gov/pubmed/33198777 http://dx.doi.org/10.1186/s12967-020-02606-3

Ejemplares similares

Prognostic factors and survival outcomes according to tumor subtype in patients with breast cancer lung metastases
por: Chen, Siying, et al.
Publicado: (2019)

Construction of a Nomogram for Predicting Survival in Elderly Patients With Lung Adenocarcinoma: A Retrospective Cohort Study
por: You, Haisheng, et al.
Publicado: (2021)

SE translation mRNA overexpression: a potential prognostic predictor in breast cancer
por: Du, Qian, et al.
Publicado: (2019)

Prognostic value of Beclin 1, EGFR and ALK in non-squamous non-small cell lung cancer
por: Wan, Yanhui, et al.
Publicado: (2022)

Development and Validation of a Nomogram for Predicting Survival in Male Patients With Breast Cancer
por: Chen, Siying, et al.
Publicado: (2019)

The Prognostic Value of Biomarkers on Detecting Non-Small Cell Lung Cancer in a Chinese Elderly Population
por: Guo, Lianghua, et al.
Publicado: (2021)

Associations between ABCG2 gene polymorphisms and gefitinib toxicity in non-small cell lung cancer: a meta-analysis
por: Tang, Lina, et al.
Publicado: (2018)

Poor prognosis of nucleophosmin overexpression in solid tumors: a meta-analysis
por: Chen, Siying, et al.
Publicado: (2018)

SB-T-121205, a next-generation taxane, enhances apoptosis and inhibits migration/invasion in MCF-7/PTX cells
por: Zheng, Xiaowei, et al.
Publicado: (2017)

SB-T-121205, a next-generation taxane, enhances apoptosis and inhibits migration/invasion in MCF-7/PTX cells
por: Zheng, Xiaowei, et al.
Publicado: (2022)

SB-T-121205, a next-generation taxane, enhances apoptosis and inhibits migration/invasion in MCF-7/PTX cells
por: Zheng, Xiaowei, et al.
Publicado: (2023)

PD-L1 expression as poor prognostic factor in patients with non-squamous non-small cell lung cancer
por: Zhou, Cuiling, et al.
Publicado: (2017)

Different prognostic impact of STK11 mutations in non-squamous non-small-cell lung cancer
por: Pécuchet, Nicolas, et al.
Publicado: (2015)

Distinct Prognostic Values of Alcohol Dehydrogenase Family Members for Non-Small Cell Lung Cancer
por: Wang, Peng, et al.
Publicado: (2018)

Prognostic factors of 112 elderly patients with advanced non-small cell lung cancer
por: Ran, Fanglan, et al.
Publicado: (2022)

Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma
por: Li, Na, et al.
Publicado: (2021)

Prognostic significance of KRT19 in Lung Squamous Cancer
por: Yuan, Xun, et al.
Publicado: (2021)

Nanoparticle albumin‐bound paclitaxel in elder patients with advanced squamous non‐small‐cell lung cancer: A retrospective study
por: Liu, Yang, et al.
Publicado: (2019)

Construction and validation of prognostic nomograms for elderly patients with metastatic non‐small cell lung cancer
por: Sun, Haishuang, et al.
Publicado: (2022)

Case Report: Replacement of PD-1 inhibitors with PD-L1 inhibitors in the treatment of squamous non-small-cell lung carcinoma
por: Wu, Tong, et al.
Publicado: (2023)

Prognostic Impact of TTF-1 Expression in Non-Squamous Non-Small-Cell Lung Cancer: A Meta-Analysis
por: Kim, Jung Han, et al.
Publicado: (2018)

Elevated expression of podoplanin and its clinicopathological, prognostic, and therapeutic values in squamous non-small cell lung cancer
por: Xie, Liyi, et al.
Publicado: (2018)

Prognostic Value of Malic Enzyme and ATP-Citrate Lyase in Non-Small Cell Lung Cancer of the Young and the Elderly
por: Csanadi, Agnes, et al.
Publicado: (2015)

Phase I dose escalation study of pemetrexed and concurrent thoracic radiation in elderly patients with non-squamous non–small-cell lung cancer
por: Kaira, Kyoichi, et al.
Publicado: (2019)

Presence of a 34-gene signature is a favorable prognostic marker in squamous non-small cell lung carcinoma
por: Theelen, W. S. M. E., et al.
Publicado: (2020)

Preoperative splenic area as a prognostic biomarker of early-stage non-small cell lung cancer
por: Liu, Mengmei, et al.
Publicado: (2023)

Direct bilirubin levels are prognostic in non-small cell lung cancer
por: Song, Ying-Jian, et al.
Publicado: (2017)

Are TKIs favourable for the elderly with non-small-cell lung cancer?
por: Rossi, Sabrina, et al.
Publicado: (2016)

Phase I study of pemetrexed and concurrent radiotherapy for previously untreated elderly patients with locally advanced non‐squamous non‐small cell lung cancer
por: Takemoto, Shinnosuke, et al.
Publicado: (2017)

Integrated Analysis of the Functions and Prognostic Values of RNA Binding Proteins in Lung Squamous Cell Carcinoma
por: Li, Wei, et al.
Publicado: (2020)

Prognostic value of TIM-1 expression in human non-small-cell lung cancer
por: Zheng, Xiao, et al.
Publicado: (2019)

Eligibility for Bevacizumab as an Independent Prognostic Factor for Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer: A Retrospective Cohort Study
por: Takagi, Yusuke, et al.
Publicado: (2013)

Clinical associations and prognostic value of site-specific metastases in non-small cell lung cancer: A population-based study
por: Xu, Zihan, et al.
Publicado: (2019)

miR-486 as an unfavorable prognostic biomarker for patients with non-small cell lung cancer
por: Gao, Zhao-Jia, et al.
Publicado: (2020)

Association of BTLA Polymorphisms with Susceptibility to Non-Small-Cell Lung Cancer in the Chinese Population
por: Wang, Jusi, et al.
Publicado: (2021)

SPARC expression and prognostic value in non-small cell lung cancer
por: Huang, Yan, et al.
Publicado: (2012)

Characteristics of hypoxic tumor microenvironment in non-small cell lung cancer, involving molecular patterns and prognostic signature
por: Huang, Zhanghao, et al.
Publicado: (2021)

Autophagy characteristics and establishment of autophagy prognostic models in lung adenocarcinoma and lung squamous cell carcinoma
por: Chen, Zhubei, et al.
Publicado: (2022)

Camrelizumab in patients with advanced non-squamous non-small cell lung cancer: a cost-effective analysis in China
por: Xie, Qian, et al.
Publicado: (2022)

Prognostic influence of PD-1/PD-L1 suppressors in combination with chemotherapeutic agents for non-small cell pulmonary carcinoma: system review and meta-analysis
por: Shen, Min, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_uj52kfbpmq6gif881tcsb907v1